Filing Details
- Accession Number:
- 0001144204-14-008740
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2014-02-13 19:25:46
- Reporting Period:
- 2011-12-27
- Filing Date:
- 2014-02-13
- Accepted Time:
- 2014-02-13 19:25:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1335103 | Protea Biosciences Group Inc. | NONE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529365 | Scott Segal | 955 Hartman Run Road Morgantown WV 26507 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share ("Common Stock") | Acquisiton | 2011-12-27 | 50,000 | $2.00 | 1,569,123 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2013-07-23 | 388,038 | $0.50 | 1,957,161 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2011-12-27 | 25,000 | $0.00 | 25,000 | $2.25 |
Common Stock | Warrant | Acquisiton | 2013-07-23 | 291,029 | $0.00 | 291,029 | $1.10 |
Common Stock | Convertible Notes | Disposition | 2013-07-23 | 388,038 | $194,019.00 | 0 | $0.50 |
Common Stock | Stock Option | Acquisiton | 2008-05-30 | 100,000 | $150,000.00 | 100,000 | $1.50 |
Common Stock | Stock Option | Acquisiton | 2013-03-22 | 218,750 | $120,313.00 | 218,750 | $0.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
933,334 | 2011-12-27 | 2016-12-27 | No | 4 | P | Direct |
1,224,363 | 2013-06-30 | 2018-07-23 | No | 4 | P | Direct |
1,224,363 | 2013-07-23 | 2013-07-23 | No | 4 | C | Direct |
1,324,363 | 2008-05-30 | 2018-05-30 | No | 4 | A | Direct |
1,209,779 | 2013-03-22 | 2023-03-22 | No | 4 | A | Direct |
Footnotes
- On December 27, 2011 (the "December Closing Date"), the Company issued to Scott Segal (the "Reporting Person") one unit (the "Unit"), consisting of 50,000 shares of the Company's common stock, at a price of $2.00 per share, and a warrant (the "Warrant") to purchase 25,000 shares of Common Stock at an exercise price of $2.25 per share.
- On April 16, 2012, the Company issued a Convertible Promissory Note to the Reporting Person in the aggregate principal amount of $100,000. On September 25, 2012 the Company issued a convertible promissory note to the Reporting Person in the aggregate principal amount of $75,000. On March 22, 2013, the Company approved a reduction in the conversion price to $0.50 per share. On June 30, 2013, pursuant to the terms and conditions of a Conversion Agreement, dated June 18, 2013, outstanding principal and interest equal to $194,019 was converted into 388,038 shares of common stock.
- Pursuant to the Conversion Agreement, upon conversion of the April Note and September Note, the Company agreed to issue a warrant to purchase 75% of the number of shares into which the notes are convertible.
- Represents shares vested as of February 10, 2014.
- Reflects the expiration of previously reported warrants to purchase 333,334 shares of common stock held by the Reporting Person.